Product
Help
Pricing
About
Jobs
Log in
Get started
Award
Add to collection
ALFGBG-965240
Funder:
UK Dementia Research Institute
Funded outputs count:
68
Funder award ID:
ALFGBG-965240
OpenAlex ID:
G7804671150
Spatiotemporal characterization of Alzheimer disease pathology in living human brain tissue
2026
·
Aram Aslanyan
, Soumya Mukherjee
, et al.
·
Nature Communications
·
1
PDF
CSF p-tau205: a biomarker of Alzheimer’s disease progression and biological staging
2026
·
Juan Lantero-Rodriguez
, Shorena Janelidze
, et al.
·
Molecular Psychiatry
PDF
Astrocyte reactivity modifies the effects of locus coeruleus norepinephrine‐related dysfunction on tau and its impact on cognition
2026
·
Prokopis C. Prokopiou
, Maxime Van Egroo
, et al.
·
Alzheimer s & Dementia
Spatiotemporal dynamics of tau extent and load increase in Alzheimer’s disease across four longitudinal cohorts
2026
·
Arthur C. Macedo
, Lydia Trudel
, et al.
·
Nature Aging
·
10
Performance of Alzheimer Disease Plasma Biomarkers in Patients With Prion Diseases
2026
·
Thomas Coysh
, Rhiannon Laban
, et al.
·
Neurology
·
3
Neurofilament light chain and glial fibrillary acidic protein as biomarkers of peripheral nervous system involvement in multiple sclerosis: diagnostic and prognostic evaluation
2026
·
Alina Flintere-Flinte
, Vladimirs Krutovs
, et al.
·
BMC Neurology
Cerebrospinal fluid and frontal cortex TMPRSS2 and ACE2 protein levels differ in Down syndrome and Alzheimer’s disease
2026
·
Carlos Avilés-Granados
, Adriana Gea-González
, et al.
·
Acta Neuropathologica Communications
Analytical and clinical validation of the Lumipulse G plasma p‐tau217 assay for clinical implementation
2026
·
Burak Arslan
, Johan Gobom
, et al.
·
Alzheimer s & Dementia
·
4
Cerebrospinal fluid NPTX2/p‐tau ratio as a biomarker for cognitive decline in neurodegenerative diseases
2026
·
Bárbara Fernandes Gomes
, Mathias Sauer
, et al.
·
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
·
2
Selective reduction of ADAM10 in brain and cerebrospinal fluid of Alzheimer’s disease patients
2026
·
Adriana Gea-González
, Renata Valle-Pedroso
, et al.
·
Alzheimer s Research & Therapy
·
1
Glymphatic dysfunction links vascular pathology to Alzheimer’s biomarkers and cognitive decline
2026
·
Sung Hoon Kang
, Seongmi Kim
, et al.
·
Alzheimer s Research & Therapy
·
11
Early functional changes and plasma GFAP in Swedish families with Autosomal Dominant Alzheimer’s disease mutations
2026
·
Emma S. Luckett
, Mariola Zapater-Fajari
, et al.
·
Translational Psychiatry
·
1
PDF
Cerebrospinal fluid levels of neurogranin and YKL-40 in mild cognitive impairment due to Alzheimer's disease or vascular dementia
2026
·
Ulla Andin
, Svante Lifvergren
, et al.
·
Journal of Alzheimer s Disease
A minimally invasive dried blood spot biomarker test for the detection of Alzheimer’s disease pathology
2026
·
Hanna Huber
, Laia Montoliu-Gaya
, et al.
·
Nature Medicine
·
44
PDF
Increased cerebrospinal fluid YKL-40 concentration in hip fracture patients with delirium
2026
·
Thea Berntsen
, Kaj Blennow
, et al.
·
Brain Communications
·
1
PDF
Association of acute blood biomarkers with diffusion tensor imaging and outcome in patients with traumatic brain injury presenting with GCS of 13–15
2025
·
Malla Mononen
, Mehrbod Mohammadian
, et al.
·
NeuroImage Clinical
·
3
APOE ɛ4 carriership determines a faster plasma p‐tau217 progression in Aβ‐positive individuals
2025
·
Marcel S. Woo
, Arthur C Macedo
, et al.
·
Alzheimer s & Dementia
·
4
Diagnostic Value of Serum p-tau217 in Alzheimer Disease: Equal to Plasma in Levels and Clinical Utility?
2025
·
Andrea L Benedet
, Burak Arslan
, et al.
·
Clinical Chemistry
·
15
Cerebrospinal fluid proteomic associations of APOE genotypes reveal distinct protective and risk mechanisms for Alzheimer's disease
2025
·
Eleonora M. Vromen
, Senne B. Lageman
, et al.
·
Alzheimer s & Dementia
·
8
PDF
Predicting cognitive decline with amyloid‐PET, plasma p‐tau217, Aβ42/40, and p‐tau217/Aβ42 in a community‐based cohort – relevance for clinical trial enrollment
2025
·
Dario Bachmann
, Maha Wybitul
, et al.
·
Alzheimer s & Dementia
·
6
PDF
Neurofilament, but not Alzheimer disease biomarkers in the acute phase correlate with cognitive performance after cardiac arrest
2025
·
Johannes Lorentzson
, Gisela Lilja
, et al.
·
Resuscitation Plus
·
1
Factors related to blood-based biomarkers for neurodegenerative diseases and their intergenerational associations in the Young Finns Study: a cohort study
2025
·
Marja A Heiskanen
, Juha Mykkänen
, et al.
·
The Lancet Healthy Longevity
·
11
PDF
Chemical imaging delineates Aβ plaque polymorphism across the Alzheimer’s disease spectrum
2025
·
Srinivas Koutarapu
, Junyue Ge
, et al.
·
Nature Communications
·
31
Plasma p‐tau212 as a biomarker of sporadic and Down syndrome Alzheimer's disease
2025
·
Przemysław R. Kac
, Daniel Alcolea
, et al.
·
Alzheimer s & Dementia
·
23
PDF
Data‐driven evaluation of suitable immunogens for improved antibody selection
2025
·
Katharina Waury
, Hlin Kvartsberg
, et al.
·
Protein Science
·
2
Show more works
View as search